National Recruitment Efforts Underway for
Director of
Oncology Drug Products in CDER’s Office of New Drugs
The U.S. Food and Drug
Administration, Center for Drug Evaluation and Research (CDER), is seeking a
highly skilled and dedicated individual to serve as the Director of the newly
established Office of Oncology Drug Products in CDER’s Office of New Drugs, currently located in Rockville,
MD. The Office Director will have the unique opportunity to establish a
cross-cutting oncology program that has the potential to significantly impact
public health and the future of cancer therapy. The Director of the Office of
Oncology Drug Products will have responsibility for the regulatory oversight
and approval of both drug and biologic products to treat, diagnose, and
prevent cancer. The product scope will also include hematologic therapies,
radiation protection agents, medical imaging drugs, and radiographic agents
used to diagnose, monitor, and treat cancer and other diseases.
In addition to broad
responsibilities for cancer drug development, the Director will coordinate and
direct a cross-cutting FDA Oncology Program, including an Agency-wide Oncology
Coordinating Committee to insure proactive and consistent policies and
approaches to the development of anticancer therapies.
The Director will coordinate
this effort with other important groups, including the National Cancer
Institute,
oncology
professional
societies, and
academic centers of cancer excellence.
The ideal candidate will be
an oncologist or hematologist-oncologist who is a nationally recognized
oncology expert with knowledge of the basic science of drug development and
translational research. This individual should possess the ability to lead
large groups of highly skilled individuals and should have excellent interpersonal
skills and the ability to build consensus, coupled with an innovative and
forward-thinking viewpoint. Finally, this individual will have a strong
commitment to public health.
For more information on this
exciting opportunity, please see our recruitment advertisement in the October 15th
issue of the Journal of Clinical Oncology, or you may view the advertisement
online at
http://careercenter.jco.org.
Current permanent Federal employees in competitive positions
or former employees with reinstatement eligibility
may view and apply directly to this position at the Office of Personnel
Management (OPM) Website.
For more information on the new Office of Oncology Drug
Products, please see
FDA News: FDA to
Establish New Cancer Office and Program: Changes Designed to Improve Efficiency
and Consistency of Cancer Product Reviews
Back to Top
Back to Careers
Date created: October 6, 2004, updated October 7, 2004 |